Pharmaceutical giants Pfizer and Genentech, two conglomerates with a combined market cap of over $300 billion, have introduced the MediLedger project, a blockchain platform built on top of the Ethereum protocol to prevent counterfeit medicine and pills entering large-scale supply chains of pharmaceutical companies. According to Fortune, the MediLedger Project...